Probiotics in Cosmetic and Personal Care Products: Trends and Challenges
Abstract
1. Introduction
2. Cosmetics for Skin
3. Topical Delivery and Formulation of Probiotics
4. Probiotics for Female Intimate Care
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- US Food and Drug Administration. Cosmetics Overview. Available online: https://www.fda.gov/industry/regulated-products/cosmetics-overview#cosmetic (accessed on 15 November 2020).
- Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [Google Scholar] [CrossRef]
- Probiotic Cosmetic Products Market Forecast, Trend Analysis and Competition Tracking-Global Market Insights 2020 to 2030. Available online: https://www.factmr.com/report/4188/probiotic-cosmetic-products-market (accessed on 20 December 2020).
- Ulta Beauty. Available online: https://www.ulta.com/ (accessed on 19 February 2021).
- Sephora. Available online: https://www.sephora.com (accessed on 19 February 2021).
- Kearney, M. rtweet: Collecting and analyzing Twitter data. J. Open Source Softw. 2019, 4, 1829. [Google Scholar] [CrossRef]
- Feinerer, I.; Hornik, K.; Meyer, D. Text mining infrastructure in R. J. Stat. Softw. 2008, 25. [Google Scholar] [CrossRef]
- Nakatsuji, T.; Chiang, H.-I.; Jiang, S.B.; Nagarajan, H.; Zengler, K.; Gallo, R.L. The microbiome extends to subepidermal compartments of normal skin. Nat. Commun. 2013, 4, 1431. [Google Scholar] [CrossRef] [PubMed]
- Matts, P.J. New insights into skin appearance and measurement. J. Invest. Dermatol. Symp. Proc. 2008, 13, 6–9. [Google Scholar] [CrossRef]
- Guéniche, A.; Bastien, P.; Ovigne, J.M.; Kermici, M.; Courchay, G.; Chevalier, V.; Breton, L.; Castiel-Higounenc, I. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol. 2010, 19, 1–8. [Google Scholar] [CrossRef]
- Klein, G.; Schanstra, J.P.; Hoffmann, J.; Mischak, H.; Siwy, J.; Zimmermann, K. Proteomics as a quality control tool of pharmaceutical probiotic bacterial lysate products. PLoS ONE 2013, 8, e66682. [Google Scholar] [CrossRef]
- Villa, E.; Garelli, V.; Braido, F.; Melioli, G.; Canonica, G.W. May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ. J. 2010, 3, S17–S23. [Google Scholar] [PubMed]
- Sultana, R.; McBain, A.J.; O’Neill, C.A. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl. Environ. Microbiol. 2013, 79, 4887–4894. [Google Scholar] [CrossRef] [PubMed]
- Mokrozub, V.V.; Lazarenko, L.M.; Sichel, L.M.; Babenko, L.P.; Lytvyn, P.M.; Demchenko, O.M.; Melnichenko, Y.O.; Boyko, N.V.; Biavati, B.; Digioia, D.; et al. The role of beneficial bacteria wall elasticity in regulating innate immune response. EPMA J. 2015, 6, 13. [Google Scholar] [CrossRef]
- Mohammedsaeed, W.; Cruickshank, S.; McBain, A.J.; O’Neill, C.A. Lactobacillus rhamnosus GG lysate increases re-epithelialization of keratinocyte scratch assays by promoting migration. Sci. Rep. 2015, 5, 16147. [Google Scholar] [CrossRef] [PubMed]
- Ankrah, N.Y.D.; May, A.L.; Middleton, J.L.; Jones, D.R.; Hadden, M.K.; Gooding, J.R.; LeCleir, G.R.; Wilhelm, S.W.; Campagna, S.R.; Buchan, A. Phage infection of an environmentally relevant marine bacterium alters host metabolism and lysate composition. ISME J. 2014, 8, 1089–1100. [Google Scholar] [CrossRef] [PubMed]
- Genova, E.; Pelin, M.; Decorti, G.; Stocco, G.; Sergo, V.; Ventura, A.; Bonifacio, A. SERS of cells: What can we learn from cell lysates? Anal. Chim. Acta 2018, 1005, 93–100. [Google Scholar] [CrossRef]
- Navarro-López, V.; Martínez-Andrés, A.; Ramírez-Boscá, A.; Ruzafa-Costas, B.; Núñez-Delegido, E.; Carrión-Gutiérrez, M.A.; Prieto-Merino, D.; Codoñer-Cortés, F.; Ramón-Vidal, D.; Genovés-Martínez, S.; et al. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: A randomized controlled clinical trial. Acta Derm. Venereol. 2019, 99, 1078–1084. [Google Scholar] [CrossRef]
- Yu, Y.; Dunaway, S.; Champer, J.; Kim, J.; Alikhan, A. Changing our microbiome: Probiotics in dermatology. Br. J. Dermatol. 2020, 182, 39–46. [Google Scholar] [CrossRef]
- Korpela, K.; Salonen, A.; Vepsäläinen, O.; Suomalainen, M.; Kolmeder, C.; Varjosalo, M.; Miettinen, S.; Kukkonen, K.; Savilahti, E.; Kuitunen, M.; et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarian-born infants. Microbiome 2018, 6, 182. [Google Scholar] [CrossRef]
- Sharma, D.; Kober, M.M.; Bowe, W.P. Anti-aging effects of probiotics. J. Drugs Dermatol. 2016, 15, 9–12. [Google Scholar]
- Jung, G.W.; Tse, J.E.; Guiha, I.; Rao, J. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J. Cutan Med. Surg. 2013, 17, 114–122. [Google Scholar] [CrossRef] [PubMed]
- Knackstedt, R.; Knackstedt, T.; Gatherwright, J. The role of topical probiotics in skin conditions: A systematic review of animal and human studies and implications for future therapies. Exp. Dermatol. 2020, 29, 15–21. [Google Scholar] [CrossRef] [PubMed]
- Kalliomäki, M.; Salminen, S.; Poussa, T.; Arvilommi, H.; Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet 2003, 361, 1869–1871. [Google Scholar] [CrossRef]
- Isolauri, E.; Kalliomaki, M.; Laitinen, K.; Salminen, S. Modulation of the maturing gut barrier and microbiota: A novel target in allergic disease. Curr. Pharma. Des. 2008, 14, 1368–1375. [Google Scholar] [CrossRef]
- Hubálek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 2003, 46, 205–229. [Google Scholar] [CrossRef]
- Morgan, C.A.; Herman, N.; White, P.A.; Vesey, G. Preservation of microorganisms by drying; a review. J. Microbiol. Methods 2006, 66, 183–193. [Google Scholar] [CrossRef] [PubMed]
- Yao, M.; Xie, J.; Du, H.; McClements, D.J.; Xiao, H.; Li, L. Progress in microencapsulation of probiotics: A review. Compr. Rev. Food Sci. Food Saf. 2020, 19, 857–874. [Google Scholar] [CrossRef]
- Puebla-Barragan, S.; Reid, G. Forty-five-year evolution of probiotic therapy. Microb. Cell 2019, 6, 184–196. [Google Scholar] [CrossRef] [PubMed]
- Government of Canada. Questions and Answers on Probiotics. Available online: https://www.canada.ca/en/health-canada/services/food-nutrition/food-labelling/health-claims/questions-answers-probiotics.html (accessed on 20 November 2020).
- US Food and Drug Administration. Methods for cosmetics. In Bacteriological Analytical Manual. Available online: https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam (accessed on 19 February 2021).
- Salminen, S. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. (In press).
- Marco, M.L.; Sanders, M.E.; Gänzle, M.; Arrieta, M.C.; Cotter, P.D.; De Vuyst, L.; Hill, C.; Holzapfel, W.; Lebeer, S.; Merenstein, D.; et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods. Nat. Rev. Gasteroenterol. Hepatol. 2021. [Google Scholar] [CrossRef] [PubMed]
- Chojnacka, K. Fermentation products. In Chemical Engineering and Chemical Process Technology-Volume V: Chemical Engineering Education and Main Products; Pohorecki, R., Bridgwater, J., Molzahn, M., Gani, R., Gallegos, C., Eds.; Eolss Publishers Co. Ltd.: London, UK, 2010; Volume 5. [Google Scholar]
- Reid, G.; Abrahamsson, T.; Bailey, M.; Bindels, L.B.; Bubnov, R.; Ganguli, K.; Martoni, C.; O’Neill, C.; Savignac, H.M.; Stanton, C.; et al. How do probiotics function at distant sites? Benef. Microbes 2017, 8, 521–533. [Google Scholar] [CrossRef]
- Cinque, B.; La Torre, C.; Melchiorre, E.; Marchesani, G.; Zoccali, G.; Palumbo, P.; Di Marzio, L.; Masci, A.; Mosca, L.; Mastromarino, P.; et al. Use of probiotics for dermal applications. In Microbiology Monographs; Liong, M.T., Ed.; Springer: Berlin/Heidelberg, Germany, 2011; Volume 21. [Google Scholar]
- Al-Ghazzewi, F.H.; Tester, R.F. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int. J. Cosmet. Sci. 2010, 32, 139–142. [Google Scholar]
- Rather, I.A.; Bajpai, V.K.; Huh, Y.S.; Han, Y.-K.; Bhat, E.A.; Lim, J.; Paek, W.K.; Park, Y.-H. Probiotic Lactobacillus sakei proBio-65 extract ameliorates the severity of imiquimod induced psoriasis-like skin inflammation in a mouse model. Front. Microbiol. 2018, 9, 1021. [Google Scholar] [CrossRef]
- Sonal Sekhar, M.; Unnikrishnan, M.K.; Vijayanarayana, K.; Rodrigues, G.S.; Mukhopadhyay, C. Topical application/formulation of probiotics: Will it be a novel treatment approach for diabetic foot ulcer? Med. Hypotheses. 2014, 82, 86–88. [Google Scholar] [CrossRef]
- Rudis, B.; Gandy, D. Waffle: Create Waffle Chart Visualizations. Available online: https://gitlab.com/hrbrmstr/waffle (accessed on 19 February 2021).
- Bruce, A.W.; Chadwick, P.; Hassan, A.; VanCott, G.F. Recurrent urethritis in women. Can. Med. Assoc. J. 1973, 108, 973–976. [Google Scholar] [PubMed]
- Bruce, A.W.; Reid, G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can. J. Microbiol. 1988, 34, 339–343. [Google Scholar] [CrossRef]
- Reid, G.; Bruce, A.W.; Fraser, N.; Heinemann, C.; Owen, J.; Henning, B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 2001, 30, 49–52. [Google Scholar] [CrossRef]
- Stapleton, A.E.; Au-Yeung, M.; Hooton, T.M.; Fredricks, D.N.; Roberts, P.L.; Czaja, C.A.; Yarova-Yarovaya, Y.; Fiedler, T.; Cox, M.; Stamm, W.E. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin. Infect. Dis. 2011, 52, 1212–1217. [Google Scholar] [CrossRef] [PubMed]
- Verdenelli, M.C.; Cecchini, C.; Coman, M.M.; Silvi, S.; Orpianesi, C.; Coata, G.; Cresci, A.; Di Renzo, G.C. Impact of probiotic SYNBIO® administered by vaginal suppositories in promoting vaginal health of apparently healthy women. Curr. Microbiol. 2016, 73, 483–490. [Google Scholar] [CrossRef] [PubMed]
- Rossi, A.; Rossi, T.; Bertini, M.; Caccia, G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch. Gynecol. Obstet. 2010, 281, 1065–1069. [Google Scholar] [CrossRef]
- Petricevic, L.; Witt, A. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. Gen. Gynaecol. 2008, 1369–1374. [Google Scholar] [CrossRef] [PubMed]
- Larsson, P.-G.; Brandsborg, E.; Forsum, U.; Pendharkar, S.; Andersen, K.K.; Nasic, S.; Hammarström, L.; Marcotte, H. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect. Dis. 2011, 11, 223. [Google Scholar] [CrossRef] [PubMed]
- Anukam, K.; Osazuwa, E.; Ahonkhai, I.; Ngwu, M.; Osemene, G.; Bruce, A.W.; Reid, G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo-controlled trial. Microbes Infect. 2006, 8, 1450–1454. [Google Scholar] [CrossRef] [PubMed]
- Martinez, R.C.R.; Franceschini, S.A.; Patta, M.C.; Quintana, S.M.; Candido, R.C.; Ferreira, J.C.; De Martinis, E.C.P.; Reid, G. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett. Appl. Microbiol. 2009, 48, 269–274. [Google Scholar] [CrossRef]
- Vujic, G.; Knez, A.J.; Stefanovic, V.D.; Vrbanovic, V.K. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: A double-blind, randomized, placebo-controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 168, 75–79. [Google Scholar] [CrossRef] [PubMed]
- Skokovic-Sunjic, D. Clinical Guide to Probiotic Products Available in the USA. Available online: http://www.usprobioticguide.com/PBCWomensHealth.html?utm_source=women_ind&utm_medium=civ&utm_campaign=USA_CHART (accessed on 3 January 2021).
- Skokovic-Sunjic, D. Clinical Guide to Probiotic Products Available in Canada. Available online: http://www.probioticchart.ca/PBCWomensHealth.html?utm_source=women_ind&utm_medium=civ&utm_campaign=CDN_CHART (accessed on 3 January 2021).
- AB ELLEN® Probiotic Tampon Scientific Summary. Available online: https://www.ellentampon.ch/sites/all/themes/ellen_tampon_ch/media/downloads/probiotic-tampon-scientific-information-public.pdf (accessed on 20 December 2020).
- Sauperl, O.; Zabret, A.; Fras Zemljič, L. Development of advanced sanitary materials with the use of probiotic paste. J. Eng. Fiber. Fabr. 2020, 15, 155892502092221. [Google Scholar]
- Handalishy, I.; Behery, M.; Elkhouly, M.; Farag, E.A.; Elsheikh, W.A. Comparative study between probiotic vaginal tampons and oral metronidazole in treatment of bacterial vaginosis. AAMJ 2014, 12, 185–203. [Google Scholar]
- Bilardi, J.E.; Walker, S.; Temple-Smith, M.; McNair, R.; Mooney-Somers, J.; Bellhouse, C.; Fairley, C.K.; Chen, M.Y.; Bradshaw, C. The burden of bacterial vaginosis: Women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS ONE 2013, 8, e74378. [Google Scholar]
- Fashemi, B.; Delaney, M.L.; Onderdonk, A.B.; Fichorova, R.N. Effects of feminine hygiene products on the vaginal mucosal biome. Microb. Ecol. Heal. Dis. 2013, 24. [Google Scholar] [CrossRef] [PubMed]
- Brotman, R.M.; Klebanoff, M.A.; Nansel, T.R.; Andrews, W.W.; Schwebke, J.R.; Zhang, J.; Yu, K.F.; Zenilman, J.M.; Scharfstein, D.O. A longitudinal study of vaginal douching and bacterial vaginosis—a marginal structural modeling analysis. Am. J. Epidemiol. 2008, 168, 188–196. [Google Scholar] [CrossRef] [PubMed]
- McMillan, A.; Rulisa, S.; Sumarah, M.; Macklaim, J.M.; Renaud, J.; Bisanz, J.E.; Gloor, G.B.; Reid, G. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci. Rep. 2015, 5, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Puebla-Barragan, S.; Renaud, J.; Sumarah, M.; Reid, G. Malodorous biogenic amines in Escherichia coli-caused urinary tract infections in women—a metabolomics approach. Sci. Rep. 2020, 10, 9703. [Google Scholar] [CrossRef]
- Donders, G.; Bellen, G.; Oerlemans, E.; Claes, I.; Ruban, K.; Henkens, T.; Kiekens, F.; Lebeer, S. The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: A proof-of-concept study. Eur. J. Clin. Microbiol. Infect. Dis. 2020, 39, 1551–1558. [Google Scholar] [CrossRef]
- Iwamoto, T.; Suzuki, N.; Tanabe, K.; Takeshita, T.; Hirofuji, T. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: An open-label pilot trial. Oral Surgery, Oral Med. Oral Pathol. Oral Radiol. Endod. 2010, 110, 201–208. [Google Scholar] [CrossRef] [PubMed]
- Masdea, L.; Kulik, E.; Hauser-Gerspach, I.; Ramseier, A.; Filippi, A.; Waltimo, T.; Masdea, L.; Kulik, E.; Hauser-Gerspach, I.; Ramseier, A.; et al. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch. Oral Biol. 2012, 57, 1041–1047. [Google Scholar] [CrossRef] [PubMed]
- Burton, J.; Chilcott, C.; Moore, C.; Speiser, G.; Tagg, J. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J. Appl. Microbiol. 2006, 100, 754–764. [Google Scholar] [CrossRef] [PubMed]
- Lebeer, S.; Oerlemans, E.; Claes, I.; Wuyts, S.; Henkens, T.; Spacova, I.; van den Broek, M.; Tuyaerts, I.; Wittouck, S.; De Boeck, I.; et al. Topical cream with live lactobacilli modulates the skin microbiome and reduce acne symptoms. bioRxiv 2018. [Google Scholar] [CrossRef]
TYPE OF PRODUCT | PROPORTION OF PRODUCTS |
---|---|
Deodorant | 2% |
Primer | 2% |
Balm | 4% |
Soap bar | 4% |
Foundation | 6% |
Cleanser | 10% |
Exfoliant | 10% |
Gel | 10% |
Mask | 12% |
Serum | 16% |
Cream | 24% |
PRODUCT ID | TYPE OF PRODUCT | LIST OF INGREDIENTS |
---|---|---|
1 | Balm | Lactococcus ferment lysate |
2 | Balm | Lactobacillus ferment |
3 | Cleanser | Bifida ferment lysate * |
4 | Cleanser | Lactobacillus ferment |
5 | Cleanser | Lactobacillus ferment |
6 | Cleanser | Bifida ferment lysate * |
7 | Cleanser | Lactobacillus ferment |
8 | Cream | Lactobacillus ferment, Lactococcus ferment lysate, Bifida ferment lysate *, Lactobacillus, Streptococcus thermophilus ferment |
9 | Cream | Lactobacillus ferment |
10 | Cream | Lactobacillus ferment |
11 | Cream | Lactobacillus ferment |
12 | Cream | Bifida ferment lysate * |
13 | Cream | Lactobacillus ferment |
14 | Cream | Bacillus coagulans |
15 | Cream | Lactococcus ferment lysate |
16 | Cream | Lactobacillus ferment |
17 | Cream | Lactobacillus ferment lysate |
18 | Cream | Lactobacillus ferment |
19 | Cream | Bifida ferment lysate * |
20 | Deodorant | Saccharomyces ferment filtrate |
21 | Foundation | Lactobacillus ferment |
22 | Foundation | Lactobacillus |
23 | Foundation | Lactococcus ferment lysate |
24 | Gel | Lactococcus ferment lysate |
25 | Gel | Lactobacillus, Lactococcus ferment extract |
26 | Gel | Leuconostoc ferment filtrate |
27 | Gel | Lactococcus ferment lysate |
28 | Gel | Lactobacillus, Greek yogurt, yogurt, yogurt powder |
29 | Mask | Lactobacillus, Greek yogurt, yogurt, yogurt powder |
30 | Mask | Bifida ferment lysate * |
31 | Mask | Lactococcus ferment lysate |
32 | Mask | Lactococcus ferment lysate |
33 | Mask | Lactobacillus ferment |
34 | Mask | Lactobacillus ferment, Lactococcus ferment lysate, Bifida ferment lysate *, Lactobacillus, Streptococcus thermophilus ferment |
35 | Exfoliant | Lactobacillus ferment |
36 | Exfoliant | Lactococcus ferment lysate |
37 | Primer | Saccharomyces ferment filtrate |
38 | Exfoliant | Lactobacillus ferment lysate, Leuconostoc ferment filtrate |
39 | Exfoliant | Saccharomyces ferment filtrate |
40 | Exfoliant | Lactobacillus ferment lysate, Leuconostoc ferment filtrate |
41 | Serum | Lactococcus ferment lysate |
42 | Serum | Lactobacillus ferment, Lactococcus ferment lysate, Bifida ferment lysate *, Lactobacillus, Streptococcus thermophilus ferment |
43 | Serum | Lactobacillus bulgaricus ferment filtrate |
44 | Serum | Bifida ferment lysate * |
45 | Serum | Lactobacillus ferment extract |
46 | Serum | Bifida ferment lysate * |
47 | Serum | Lactobacillus |
48 | Serum | Bifida ferment lysate * |
49 | Soap bar | Bifida ferment lysate * |
50 | Soap bar | Yogurt |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Puebla-Barragan, S.; Reid, G. Probiotics in Cosmetic and Personal Care Products: Trends and Challenges. Molecules 2021, 26, 1249. https://doi.org/10.3390/molecules26051249
Puebla-Barragan S, Reid G. Probiotics in Cosmetic and Personal Care Products: Trends and Challenges. Molecules. 2021; 26(5):1249. https://doi.org/10.3390/molecules26051249
Chicago/Turabian StylePuebla-Barragan, Scarlett, and Gregor Reid. 2021. "Probiotics in Cosmetic and Personal Care Products: Trends and Challenges" Molecules 26, no. 5: 1249. https://doi.org/10.3390/molecules26051249
APA StylePuebla-Barragan, S., & Reid, G. (2021). Probiotics in Cosmetic and Personal Care Products: Trends and Challenges. Molecules, 26(5), 1249. https://doi.org/10.3390/molecules26051249